NFE2L2 and Friedreich ataxia: Chromatin Immunoprecipitation (ChIP) experiments were carried out in drug-treated FA patient lymphoblasts, using an antibody to pull down Nrf2 and PCR using primers to the potential ARE sites in FXN or control Nrf2-target genes.